Biology Reference
In-Depth Information
Chapman TL, Bjorkman PJ (1998) Characterization of a murine cytomegalovirus class I major
histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the
human cytomegalovirus MHC homolog. J Virol 72:460-466
Chapman TL, Heikeman AP, Bjorkman PJ (1999) The inhibitory receptor LIR-1 uses a common
binding interaction to recognize class I MHC molecules and the viral homolog UL18.
Immunity 11:603-613
Cheung TC, Humphreys IR, Potter KG, Norris PS, Shumway HM, Tran BR, Patterson G, Jean-
Jacques R, Yoon M, Spear PG, Murphy KM, Lurain NS, Benedict CA, Ware CF (2005)
Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus
entry mediator cosignaling pathway. Proc Natl Acad Sci USA 102:13218-13223
Child SJ, Hakki M, De Niro KL, Geballe AP (2004) Evasion of cellular antiviral responses by
human cytomegalovirus TRS1 and IRS1. J Virol 78:197-205
Child SJ, Jarrahian S, Harper VM, Geballe AP (2002) Complementation of vaccinia virus lacking the
double-stranded RNA-binding protein gene E3L by human cytomegalovirus. J Virol 76:4912-4918
Chin KC, Cresswell P (2001) Viperin (cig5), an IFN-inducible antiviral protein directly induced
by human cytomegalovirus. Proc Natl Acad Sci USA 98:15125-15130
Colonna M (1998) Immunology. Unmasking the killer's accomplice. Nature 391:642-643
Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML (1997) A novel immu-
noglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity
7:273-282
Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ
(2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and
stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123-133
Cresswell P, Ackerman AL, Giodini A, Peaper DR, Wearsch PA (2005) Mechanisms of MHC
class I-restricted antigen processing and cross-presentation. Immunol Rev 207:145-157
Crnkovic-Mertens I, Messerle M, Milotic I, Szepan U, Kucic N, Krmpotic A, Jonjic S,
Koszinowski UH (1998) Virus attenuation after deletion of the cytomegalovirus Fc receptor
gene is not due to antibody control. J Virol 72:1377-1382
Croft M (2003) Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
Nat Rev Immunol 3:609-620
Cull VS, Bartlett EJ, James CM (2002) Type I interferon gene therapy protects against cytomega-
lovirus-induced myocarditis. Immunology 106:428-437
Daniels KA, Devora G, Lai WC, O'Donnell CL, Bennett M, Welsh RM (2001) Murine cytomega-
lovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal anti-
body to Ly49H. J Exp Med 194:29-44
Davison AJ, Dolan A, Akter P, Addison C, Dargan DJ, Alcendor DJ, McGeoch DJ, Hayward GS
(2003) The human cytomegalovirus genome revisited: comparison with the chimpanzee
cytomegalovirus genome. J Gen Virol 84:17-28
DeFilippis VR, Früh KJ (2005) Rhesus cytomegalovirus particles prevent activation of interferon
regulatory factor 3. J Virol 79:6419-6431
DeFilippis VR, Robinson B, Keck TM, Hansen SG, Nelson JA, Früh K (2006) Interferon regula-
tory factor 3 is necessary for induction of antiviral genes during human cytomegalovirus infec-
tion. J Virol 80:1032-1037
Diefenbach A, Raulet DH (2003) Innate immune recognition by stimulatory immunoreceptors.
Curr Opin Immunol 15:37-44
Diefenbach A, Hsia JK, Hsiung MY, Raulet DH (2003) A novel ligand for the NKG2D receptor
activates NK cells and macrophages and induces tumor immunity. Eur J Immunol 33:381-391
Dighe A, Rodriguez M, Sabastian P, Xie X, McVoy M, Brown MG (2005) Requisite H2k role in
NK cell-mediated resistance in acute murine cytomegalovirus-infected MA/My mice. J Immunol
175:6820-6828
Dimasi N, Biassoni R (2005) Structural and functional aspects of the Ly49 natural killer cell
receptors. Immunol Cell Biol 83:1-8
Dunn C, Chalupny NJ, Sutherland CL, Dosch S, Sivakumar PV, Johnson DC, Cosman D (2003)
Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D lig-
ands, protecting against natural killer cell cytotoxicity. J Exp Med 197:1427-1439
